Pleiotropic effects of factor Xa and thrombin: what to expect from novel anticoagulants
Open Access
- 2 January 2014
- journal article
- review article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 101 (3) , 344-351
Abstract
Factor Xa and thrombin are well-known components of the coagulation cascade and have been proven to be viable targets for effective anticoagulation treatment. However, accumulating evidence suggests that these serine proteases are also crucial modulators of other cellular mechanisms through the activation of protease-activated receptor (PAR)-mediated signalling. The involvement of factor Xa, thrombin, and PARs in normal biological and pathophysiological processes has been recognized, and their potential implications have been explored in recent years. Both factor Xa and thrombin play significant roles in mediating cellular signalling effects associated with the initial development of atherosclerosis: a chronic inflammatory vascular disease. In addition, increased expression and activation of PARs may be associated with atrial fibrillation (AF) and AF-associated thromboembolism hypercoagulability. Both pathologies are associated with hypercoagulability, suggesting that the role of cellular effects of factor Xa and thrombin and of their specific inhibitors should be studied in relation to the prevention of thrombotic and pro-arrhythmic changes. This review examines the role of factor Xa-mediated and thrombin-mediated PAR activation in modulating cellular processes involved in atherosclerosis and AF and discusses the potential implication of direct factor Xa and thrombin inhibition on effects outside coagulation.Keywords
This publication has 60 references indexed in Scilit:
- An Immunohistochemical Analysis of Tissue Thrombin Expression in the Human AtriaPLOS ONE, 2013
- Genetic and Pharmacological Modifications of Thrombin Formation in Apolipoprotein E-deficient Mice Determine Atherosclerosis Severity and Atherothrombosis Onset in a Neutrophil-Dependent MannerPLOS ONE, 2013
- Protease-Activated Receptor-2 Modulates Protease-Activated Receptor-1–Driven Neointimal HyperplasiaArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Determinants of the specificity of protease‐activated receptors 1 and 2 signaling by factor Xa and thrombinJournal of Cellular Biochemistry, 2011
- Protease‐activated receptors and myocardial infarctionIUBMB Life, 2011
- Protease-Activated Receptor 2 Deficiency Reduces Cardiac Ischemia/Reperfusion InjuryArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Factor X/Xa Elicits Protective Signaling Responses in Endothelial Cells Directly via PAR-2 and Indirectly via Endothelial Protein C Receptor-dependent Recruitment of PAR-1Journal of Biological Chemistry, 2010
- Atherosclerosis proceeds independently of thrombin-induced platelet activation in ApoE−/− miceAtherosclerosis, 2009
- Protease-Activated Receptor-1 Contributes to Cardiac Remodeling and HypertrophyCirculation, 2007
- Thrombin Activates AMP-Activated Protein Kinase in Endothelial Cells via a Pathway Involving Ca2+/Calmodulin-Dependent Protein Kinase Kinase βMolecular and Cellular Biology, 2006